Showing results (101-110 of 326) with videos related to

Sort By:
Pageof 33
Plos One|April 2, 2015
Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individualsHinta Meijerink, Agnes Indrati, Fitri Utami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2019
Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis TrialsElin M Svensson, Sofiati Dian, Lindsey Te Brake, et al.
The Lancet Regional Health. Southeast Asia|March 14, 2024
Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysisBony Wiem Lestari, Gerine Nijman, Alamanda Larasmanah, et al.
Cytokine|August 24, 2025
Aspergillus fumigatus and Mycobacterium tuberculosis synergistically induce TNF and IL-1β via different pathways in human peripheral blood mononuclear cellsIntan M W Dewi, Mariolina Bruno, Nico A F Janssen, et al.
Plos Neglected Tropical Diseases|January 18, 2013
Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from IndonesiaA Rizal Ganiem, Sofiati Dian, Agnes Indriati, et al.
Journal of Diabetes Research|April 9, 2016
Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty AcidsEkta Lachmandas, Corina N A M van den Heuvel, Michelle S M A Damen, et al.
Acta Medica Indonesiana|November 19, 2009
Prevention and treatment of HIV addicted patients: a biopsychosocial approachShelly Iskandar, Reinout van Crevel, I M P Siregar, et al.
Addiction (Abingdon, England)|March 25, 2010
Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in IndonesiaRudi Wisaksana, Agnes K Indrati, Azzania Fibriani, et al.
Plos One|November 13, 2020
Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitisSofiati Dian, Robby Hermawan, Arjan van Laarhoven, et al.
The Lancet. Infectious Diseases|October 30, 2012
Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trialRovina Ruslami, A Rizal Ganiem, Sofiati Dian, et al.
Pageof 33